Shigeyasu Sugawara

Prognostic clinical indicators in patients with metastatic castration-resistant prostate cancer treated with radium-223 plus enzalutamide: Data from patients in J-RAP-BSI trial.

OBJECTIVE: Ra) and enzalutamide combination therapy. SUBJECTS AND METHODS: Ra and enzalutamide at 14 hospitals and had pretreatment bone scintigraphy findings available for analysis. Associations of overall survival (OS) with clinicopathological factors, including Eastern Coopera...

Differentiation of Non-Hematologic Diseases Presenting with Diffuse Splenic Fluorodeoxyglucose Uptake Based on Bone Marrow and Lymph Node Accumulation Patterns

Abstract The goal is to assess whether bone marrow (BM) and lymph node (LN) uptake patterns can explain diffuse splenic uptake in non-hematologic conditions. Among 219 patients with high splenic uptake detected on 18F-FDG positron emission tomography/computed tomography between J...